Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 12 min ago
Peer-reviewedLicence not statedMolecular and Clinical Oncology

Role of PET/CT in diffuse large B-cell lymphoma (Review)

  1. 1Department of Hematology, The Third Norman Bethune Hospital, Jilin University, Changchun, Jilin 130033, P.R. China

Related

  1. Cavitary Lung Lesion as the Initial Presentation of Diffuse Large B-Cell Lymphoma: A Case Report With Review of the Literature.
    Hannah Mckenney, Sidharth Mahajan, Ronald Lands
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Successful salvage therapy with glofitamab followed by selinexor maintenance in an elderly patient with primary refractory diffuse large b-cell lymphoma harboring TP53 and CD58 mutations: a case report and literature review
    Yurong Zhang, Huan Liu, Liangliang Li +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  3. Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B-cell lymphoma: Molecular mechanisms and therapeutic implications (Review)
    Chuanyang Lu, Tingting Zhou, Wenxin Zhang +5
    International Journal of OncologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. Primary renal diffuse large B cell lymphoma misdiagnosed as renal cell carcinoma : A case report
    Xintong Li, Jia Li, Shijie Sun +1
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Nasopharyngeal diffuse large b-cell lymphoma in a teenage presenting with cavernous sinus syndrome: A case report
    Radiology case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{jing2026role,
  title = {{Role of PET/CT in diffuse large B-cell lymphoma (Review)}},
  author = {Haoran Jing and Hui Shao and Di Zhou and Lintao Bi},
  journal = {Molecular and Clinical Oncology},
  year = {2026},
  month = oct,
  doi = {10.3892/mco.2026.2980},
  url = {https://doi.org/10.3892/mco.2026.2980},
}
RIS
TY  - JOUR
TI  - Role of PET/CT in diffuse large B-cell lymphoma (Review)
AU  - Haoran Jing
AU  - Hui Shao
AU  - Di Zhou
AU  - Lintao Bi
PY  - 2026
DA  - 2026/10/16
JO  - Molecular and Clinical Oncology
DO  - 10.3892/mco.2026.2980
UR  - https://doi.org/10.3892/mco.2026.2980
SN  - 2049-9450
SN  - 2049-9469
ER  -